Literature DB >> 12018470

Cost of infectious diseases.

C Ruef.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12018470     DOI: 10.1007/s15010-002-7202-8

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  11 in total

1.  Pitfalls associated with commonly used methods for pharmacoeconomic analyses.

Authors:  Donald G Klepser
Journal:  Pharmacotherapy       Date:  2002-02       Impact factor: 4.705

2.  Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.

Authors:  H A Pollack
Journal:  Med Decis Making       Date:  2001 Sep-Oct       Impact factor: 2.583

3.  The increasing burden of infectious diseases on hospital services at St Mary's Hospital Lacor, Gulu, Uganda.

Authors:  S Accorsi; M Fabiani; M Lukwiya; P A Onek; P D Mattei; S Declich
Journal:  Am J Trop Med Hyg       Date:  2001 Mar-Apr       Impact factor: 2.345

4.  Prevalence of nosocomial infections--who knows the true rates?

Authors:  C Ruef
Journal:  Infection       Date:  1997 Jul-Aug       Impact factor: 3.553

5.  Infectious disease consultation and microbiologic surveillance for intensive care unit trauma patients: a pilot study.

Authors:  B C Fox; P B Imrey; M B Voights; S Norwood
Journal:  Clin Infect Dis       Date:  2001-11-09       Impact factor: 9.079

6.  Long-term impact of highly active antiretroviral therapy on HIV-related health care costs.

Authors:  P Keiser; N Nassar; M B Kvanli; D Turner; J W Smith; D Skiest
Journal:  J Acquir Immune Defic Syndr       Date:  2001-05-01       Impact factor: 3.731

7.  Resource utilization and hospital cost of HIV/AIDS care in Italy in the era of highly active antiretroviral therapy.

Authors:  L Garattini; F Tediosi; E Di Cintio; D Yin; F Parazzini
Journal:  AIDS Care       Date:  2001-12

8.  Whither infectious diseases consultations? Analysis of 14,005 consultations from a 5-year period.

Authors:  A M Yinnon
Journal:  Clin Infect Dis       Date:  2001-10-10       Impact factor: 9.079

9.  Nosocomial pneumonia: a cost-of-illness analysis.

Authors:  E S Dietrich; M Demmler; G Schulgen; K Fekec; O Mast; K Pelz; F D Daschner
Journal:  Infection       Date:  2002-04       Impact factor: 3.553

Review 10.  Molecular approaches to diagnosing and managing infectious diseases: practicality and costs.

Authors:  M A Pfaller
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.